23andMe Holding Co. T.ME

Primary Symbol: ME

23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.

NDAQ:ME - Post by User

23andMe Holding Co.

<< Previous

Bullboard Posts

Next >>

Post by goldennorthon Feb 18, 2022 9:42am

234 Views

Post# 34441426

Heading In The Right Direction.

They are heading in the right direction.

"Taking a step back to appreciate the big picture, we note that hits for all reported holes at Halfway <300m vertical average 27m @ 0.6g/t at 226m depth are useful ounce additions."

https://sprott.com/media/4895/220217-me-scp-drilling.pdf

Figure 1: Tower Gold Project: General Location Map